156
Xeris Biopharma Holdings, Inc.
Metrics score locked — part of Premium
FY23
FY23
FY24
FY24
FY25
FY23 – FY25
Assets
(positive)
Change from FY23 to FY25
millions USD
FY23:
FY23:
156
FY24:
173
FY24:
168
FY25:
240
(positive)
Change from FY23 to FY25
millions USD
FY23:
173
FY23:
166
FY24:
163
FY24:
155
FY25:
143
Total assets
Change from FY23 to FY25
millions USD
FY23:
329
FY23:
323
FY24:
337
FY24:
323
FY25:
384
Liabilities & Equity
(negative)
Change from FY23 to FY25
millions USD
FY23:
79.7
FY23:
95.2
FY24:
73.1
FY24:
100
FY25:
110
(negative)
Change from FY23 to FY25
millions USD
FY23:
235
FY23:
234
FY24:
273
FY24:
252
FY25:
260
(positive)
Change from FY23 to FY25
millions USD
FY23:
13.6
FY23:
−6.78
FY24:
−9.18
FY24:
−29.6
FY25:
13.7
Total liabilities & equity
Change from FY23 to FY25
millions USD
FY23:
329
FY23:
323
FY24:
337
FY24:
323
FY25:
384
All amounts in millions USD